Introduction
Although blood pressure rises with age, it has been recognized that some individuals develop rapidly progressive blood pressure elevations with target organ injury. If these blood pressure elevations are not treated, the mortality rate in patients with target organ injury, including papilledema and declining kidney function, can exceed 50% over 6-12 months, and this hypertension is considered 'malignant' [1] . Malignant hypertension is histologically characterized by fibrinoid necrosis of arterioles and progresses rapidly. It is observed in a variety of organs, including the kidneys, pancreas, gastrointestinal tract, liver, retina, brain, myocardium, prostate, and skeletal muscles. However, pulmonary hemorrhage is rare. Here, we report a rare case of malignant hypertension with pulmonary alveolar hemorrhage.
Case
A 35-year-old man presented with cough, sudden onset progressive dyspnea, and hemoptysis. He had been previously healthy, with no history of any underlying disease.
His blood pressure was 230/140 mmHg, and he had tachypnea (28 breaths/min), without fever. He did not have bilateral pretibial edema, and neurological examination did not reveal focal signs. Urinalysis showed 3+ proteinuria and hematuria. A 35-year-old man presented with progressive dyspnea and hemoptysis. His blood pressure was 230/140 mmHg and serum creatinine level was 20.13 mg/dL. Chest radiography and computed tomography revealed pulmonary hemorrhage. His renal function was low, thus emergent renal replacement therapy was required. Malignant hypertension and acute kidney injury were diagnosed, and antihypertensive therapy and hemodialysis started immediately. Renal biopsy was performed to examine the underlying disease. Typical pathological changes of malignant hypertension, fibrinoid necrosis of the afferent arterioles, and proliferative endoarteritis at the interlobular arteries were observed. His renal function improved gradually and pulmonary hemorrhage completely disappeared with administration of antihypertensive agents. Here, we report this rare case of malignant hypertension with pulmonary alveolar hemorrhage and speculate that the hemorrhage may be related to vascular injuries at the alveolar capillary level caused by malignant hypertension. Fig. 2A, B) , and two glomeruli showed global glomerulosclerosis. Moreover, the tubules showed atrophy, flattened regenerating epithelium along the basement membrane, and some periodic acid-Schiff-positive proteinaceous casts in the lumen. Electron micrography showed diffuse subendothelial widening and mesangial expansion, and diffuse effacement of the foot processes of podocytes was noted (Fig.   2C ). Additionally, red blood cells and fibrin in the arteriolar lumen and platelet aggregation were noted, suggesting fibrinplatelet thrombus consistent with thrombotic microangiopathy (Fig. 2D) . Moreover, immunofluorescence analysis showed normal findings. Infiltration shadows in the lungs completely disappeared approximately two weeks after admission. On normalization of blood pressure, his renal function recovered gradually (Fig. 3) , and the final hemodialysis was performed on day 26 of hospitalization. His creatinine level reduced to 2.1 mg/dL. 
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He is currently on antihypertensive therapy and has stable renal function. with an increase in cardiac output, which may reduce the hypotensive response. Therefore, treatment with beta-adrenergic blockers is usually required. In the present patient, blood pressure was well controlled with these agents.
Discussion
We report a rare case of malignant hypertension with pulmonary alveolar hemorrhage and acute kidney injury that needed dialysis. In the present case, it was difficult to determine whether the malignant hypertension was primary or secondary. Renal biopsy was used to exclude the possibility of underlying systemic diseases, such as systemic angiitis syndrome and Goodpasture's disease [5] .
